Transgenic mice with low levels of global insulin-like growth factor-I (IGF-I) throughout their life span, including pre- and postnatal development, have increased longevity. This study investigated whether specific deficiency of liver-derived, endocrine IGF-I is of importance for life span.
Methods and Findings
Serum IGF-I was reduced by approximately 80% in mice with adult, liver-specific IGF-I inactivation (LI-IGF-I-/- mice), and body weight decreased due to reduced body fat. The mean life span of LI-IGF-I-/- mice (n = 84) increased 10% vs. control mice (n = 137) (Cox's test, p<0.01), mainly due to increased life span (16%) of female mice [LI-IGF-I-/- mice (n = 31): 26.7±1.1 vs. control (n = 67): 23.0±0.7 months, p<0.001]. Male LI-IGF-I-/- mice showed only a tendency for increased longevity (p = 0.10). Energy expenditure, measured as oxygen consumption during and after submaximal exercise, was increased in the LI-IGF-I-/- mice. Moreover, microarray and RT-PCR analyses showed consistent regulation of three genes (heat shock protein 1A and 1B and connective tissue growth factor) in several body organs in the LI-IGF-I-/- mice.
Adult inactivation of liver-derived, endocrine IGF-I resulted in moderately increased mean life span. Body weight and body fat decreased in LI-IGF-I-/- mice, possibly due to increased energy expenditure during exercise. Genes earlier reported to modulate stress response and collagen aging showed consistent regulation, providing mechanisms that could underlie the increased mean life span in the LI-IGF-I-/- mice.
Citation: Svensson J, Sjögren K, Fäldt J, Andersson N, Isaksson O, Jansson J-O, et al. (2011) Liver-Derived IGF-I Regulates Mean Life Span in Mice. PLoS ONE 6(7): e22640. https://doi.org/10.1371/journal.pone.0022640
Editor: Joseph Najbauer, City of Hope National Medical Center and Beckman Research Institute, United States of America
Received: December 20, 2010; Accepted: July 2, 2011; Published: July 25, 2011
Copyright: © 2011 Svensson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Swedish Research Council, the Swedish Foundation for Strategic Research, the ALF/LUA research grant in Gothenburg, the Lundberg Foundation, the Torsten and Ragnar Söderberg's Foundation, the Novo Nordisk Foundation, Sahlgrenska Center for Cardiovascular and Metabolic Research (CMR, no. A305:188), which is supported by the Swedish Strategic Foundation, and from the European Union Seventh Framework Programme (FP7/2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: Olle Isaksson was co-founder of Tercica Inc. that produced IGF-I for use in children of short stature. Tercica Inc. was acquired by Ipsen June 2008. Olle Isaksson has no current ownership of stocks or options in Tercica or Ipsen. None of the other authors has any conflict of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Insulin-like growth factor-I (IGF-I) is among the relatively few factors that regulate life span. Caenorhabditis elegans (C. elegans, a nematode) and Drosophila melanogaster (fruit fly) have common signaling pathways for IGF-I and insulin, and disruption of IGF-I/insulin signaling in these species increases longevity –. Mice have separate receptors for IGF-I and insulin, and longevity increases in several mouse strains with low global activity of the growth hormone (GH)/IGF-I axis. Spontaneous mutations in Prop-1 (Ames dwarf mice)  and Pit-1 (Snell dwarf mice)  result in impaired pituitary gland development, low GH secretion, and increased life expectancy , . Life expectancy increases in mice with deficient GH-releasing hormone receptor (Ghrhrlit/lit mice) , GH receptor null mice , and mice that are heterozygous in terms of inactivation of the IGF-I receptor in total body (Igf1r+/− mice) . Longevity also increases in mouse models with reduced IGF-I bioavailability due to knockout of the IGF binding protein (IGFBP) specific protease PAPP-A , and in mice with defective IGF-I signaling downstream of the IGF-I receptor such as mice lacking the IGF-I receptor substrate p66shc  and mice that overexpress KLOTHO . A cross-sectional study of 31 strains of mice detected an inverse correlation between plasma IGF-I levels at 6 months and median lifespan . In terms of the brain, the role of IGF-I is complex and the effects of IGF-I on lifespan and neuronal function can be uncoupled to some extent . In mice, administration of IGF-I may provide protection from neurodegeneration  while heterozygous brain-specific IGF-I receptor knockout enhances longevity .
The rate of aging is plastic and mutations in genes influencing endocrine signaling, fertility, stress responses, metabolism and telomeres can affect life span in model organisms , . Reduced body weight may participate importantly in the increased life span of long-lived, GH-deficient Ames dwarf mice, as could low fertility . However, several studies have demonstrated that reduced body size or fertility is not required for increased life span in mice with low GH/IGF-I activity , . Reduced activity of nutrient-sensing pathways, such as attenuated IGF-I signaling, may mediate some of the anti-aging effects of dietary restriction in mice . However, the prolonging effect on life span by low food intake is partly independent of IGF-I as caloric restriction prolongs life span even further in Ames dwarf mice . Furthermore, caloric restriction reduces the mitochondrial production of reactive oxidative species (ROS) and oxidative damage . In C. elegans and Drosophila melanogaster with low IGF-I/insulin activity , , , as well as in Igf1r+/− mice  and mice lacking the IGF-I receptor substrate p66shc , increased resistance to oxidative stress might be a mechanism underlying the longer life span.
The major part of serum IGF-I is liver-derived –. In addition to regulation by GH , serum IGF-I levels are also affected by food intake, exercise and age . A mouse model with liver-specific, inducible inactivation of the IGF-I gene, using the Cre-LoxP conditional knockout system, has been developed (LI-IGF-I-/- mice) , –. The selective inactivation of the IGF-I gene in the liver results in a 75-80% reduction in serum IGF-I, whereas the expression of IGF-I is unaffected in other tissues . GH secretion is increased in LI-IGF-I-/- mice secondary to a decreased negative feedback by serum IGF-I , .
Although LI-IGF-I-/- mice have no major disturbance in postnatal longitudinal bone growth , cortical bone mass is clearly decreased , , . Increased peripheral resistance in LI-IGF-I-/- mice results in elevated blood pressure . Blood glucose is normal but circulating levels of insulin and cholesterol are increased . The present study assessed the role of adult expression of liver-derived IGF-I in life span, and also investigated the importance of deficiency of liver-derived IGF-I for parameters associated with life span including fertility, body composition, oxygen consumption, activity level, food intake, and expression of longevity-associated genes in several organs.
Liver-specific inactivation of the IGF-I gene was induced in mice at one month of age in most experiments. However, food intake, body composition, oxygen consumption at rest, and activity level were measured in mice that underwent inactivation of liver-derived IGF-I at 12 months of age. In the experiments determining life span, serum IGF-I was 321±5 ng/ml in the control mice (n = 137) and 62±3 ng/ml in the LI-IGF-I-/- mice (n = 84), an 81% reduction (p<0.001). In all other experiments, serum IGF-I concentration decreased approximately 80% in the various groups of LI-IGF-I-/- mice (p<0.001 in all experiments; data not shown).
Body weight and life span
Body weight in A) female and B) male mice. Body weight was determined every third month during 3-30 months of age. Between 3 and 27 months of age, body weight was significantly lower in LI-IGF-I-/- compared with control mice in the total number of mice and also in the male and female subgroups (all analyses p<0.001). The vertical bars indicate the SE for the mean values shown.
Mean life span increased 10% [LI-IGF-I-/- mice (n = 84): 24.7±0.6 months vs. control (n = 137): 22.5±0.5 months, p<0.01 using unpaired t-test; Kaplan-Meier analysis: p = 0.001, Cox's test], mainly due to increased life span (16%) in female mice [LI-IGF-I-/- mice (n = 31): 26.7±1.1 vs. control (n = 67): 23.0±0.7 months, p<0.01 using unpaired t-test; Kaplan-Meyer analysis p<0.001, Cox's test; Fig. 2A]. Male mice showed only a tendency toward increased mean life span [6% increase; LI-IGF-I-/- mice (n = 53): 23.5±0.8 vs. control (n = 70): 22.1±0.7 months, p = 0.17 using unpaired t-test; Kaplan-Meyer analysis p = 0.10, Cox's test; Fig 2B].
A) Female LI-IGF-I-/- mice live 16% longer than female control mice (26.7 ± 1.1 vs. 23.0 ± 0.7 months, p<0.01 using unpaired t-test; Kaplan-Meyer analysis p<0.001, Cox's test). B) Although not statistically significant, male LI-IGF-I-/- mice live 6% longer than male control mice (23.5 ± 0.8 vs. 22.1 ± 0.7 months, p = 0.17 using unpaired t-test; Kaplan-Meyer analysis: p = 0.10, Cox's test).
Maximal life span of LI-IGF-I-/- mice was not significantly different compared to that of control mice (p = 0.11). In male LI-IGF-I-/- mice, maximal life span was similar as that in control mice (p = 0.92) whereas in female LI-IGF-I-/- mice, there was a non-significant tendency to increased maximum life span. When 90% of the joint distribution of female mice had died, 19% (6/31) of female LI-IGF-I-/- mice and 6% (4/67) of female control mice were still alive (p = 0.07).
When 5- and 8-month-old female control and LI-IGF-I-/- mice were mated with male controls of similar age, the proportion of pregnant females and the litter size were similar in both groups (Fig. 3A and B). Similarly, when 5- and 8-month-old male control and LI-IGF-I-/- mice were mated with female controls of similar age, the proportion of pregnant females and the litter size were similar in both groups (data not shown).
A) The percentage of pregnant female mice in relation to the total number of female mice in each group. B) Litter size when female LI-IGF-I-/- mice were mated with age-matched male control mice at 5 and 8 months of age (n = 12-14 in each group). The experiments showed normal fertility in female LI-IGF-I-/- mice. In Figure 3B, the error bars indicate the standard error for the mean values shown.
We previously demonstrated reduced body weight due to reduced body fat in 13-month-old male and female LI-IGF-I-/- mice that underwent inactivation of liver-derived IGF-I at one month of age . The present study extends those findings by investigating the effect of inactivation of IGF-I in hepatocytes at 12 months of age. Six months later, at 18 months of age, measurements using dual-energy X-ray absorptiometry (DEXA) showed reduced body fat also after correction for the reduced body weight in the LI-IGF-I-/- mice as compared with the control mice (Table 1). Absolute values of lean mass was unchanged whereas after correction for body weight, lean mass even increased in the LI-IGF-I-/- mice (Table 1). Dissections of fat pads showed lower weight of inguinal, retroperitoneal, and gonadal fat in the LI-IGF-I-/- mice as compared with the control mice (Table 1).
Food intake, activity level, and oxygen consumption
We observed no differences in food intake, feces output, oxygen consumption at rest, and spontaneous activity level while measuring 13-month-old female mice when body weight was still similar in both groups (Table 2). However, at 18 months, body weight was reduced in the female LI-IGF-I-/- mice compared with the female control mice (p<0.001; data not shown). Additional experiments to determine oxygen consumption during rest in 24-month-old female control (n = 8) and LI-IGF-I-/- (n = 5) mice that underwent inactivation of liver-derived IGF-I at one month of age showed no between-group difference (data not shown).
To further investigate mechanisms underlying reduced body fat in LI-IGF-I-/- mice, oxygen consumption during submaximal exercise and post exercise was determined in 18-month-old female control and LI-IGF-I-/- mice that underwent inactivation of liver-derived IGF-I at one month of age. The measurements showed that oxygen consumption was increased during submaximal exercise and post-exercise in LI-IGF-I-/- mice compared with controls (Fig. 4A). Respiratory exchange ratio (RER) was unchanged (Fig. 4B).
A) The volume of O2 consumed (VO2) and B) respiratory exchange ratio (RER) during submaximal exercise (30 min) and post-exercise (20 min) in 18-month-old female control (n = 7) and LI-IGF-I-/- (n = 7) mice. The vertical bars indicate the SE for the mean values shown. ** p<0.01 vs. control mice
We performed DNA microarray analyses in female control and LI-IGF-I-/- mice to identify possible mechanisms underlying increased life span. We sought to determine whether there were alterations in the global gene expression pattern that occurred consistently in various tissues, including liver, skeletal muscle, heart, fat (retroperitoneal fat) and bone (vertebrae). Four genes were regulated according to the criteria described in Materials and Methods (Table 3). Heat shock protein 1A (Hspa1a), heat shock protein 1B (Hspa1b), and connective tissue growth factor (Ctgf) were decreased in all organs that expressed these genes (Table 3). CCAAT/enhancer protein delta (Cebpd) decreased in 4 of the 5 analyzed organs (Table 3). The expression of the IGF-I receptor was unchanged in all organs studied (data not shown).
To confirm the microarray findings, we performed RT-PCR analyses on skeletal muscle (triceps) samples from individual mice. The RT-PCR analyses confirmed that mRNA levels of Hspa1a (Fig. 5A), Hspa1b (Fig. 5B), and Ctgf (Fig. 5C) decreased in LI-IGF-I-/- mice while mRNA levels of Cebpd were unchanged (data not shown). The mRNA level of the IGF-I receptor was similar in LI-IGF-I-/- and control mice (Fig. 5D).
To confirm the microarray findings, RT-PCR analyses were performed on skeletal muscle (triceps) samples from individual mice. The RT-PCR analyses showed reduced mRNA levels of A) heat shock protein 1A (Hspa1a), B) heat shock protein 1B (Hspa1b), and C) connective tissue growth factor (Ctgf). D) IGF-I receptor mRNA level was unchanged. The mRNA levels in LI-IGF-I-/- mice (n = 7) are expressed as percent of that in control mice (n = 6). The vertical bars indicate the SE for the mean values shown.* p<0.05 ** p<0.01 vs. control mice.
This study shows that deficiency of liver-derived, endocrine IGF-I results in increased mean life span. Mean life span increased significantly in female LI-IGF-I-/- mice and both genders combined, while male LI-IGF-I-/- mice showed only a tendency for increased survival. Body weight decreased in LI-IGF-I-/- mice due to reduced fat mass. We observed no between-group differences in fertility, food intake, and activity level, whereas oxygen consumption during and after submaximal exercise was increased in LI-IGF-I-/- mice. Gene expression analyses of several tissues in LI-IGF-I-/- mice identified consistent regulation of three transcripts (Hspa1a, Hspa1b, and Ctgf) that might be involved in the aging process.
Low activity of IGF-I in nematodes , , fruit flies , , and mice –,  results in increased life span. However, the role of IGF-I in adult life is difficult to evaluate in these animals due to the possible effect of absence of IGF-I activity during pre- and postnatal development. Furthermore, these previous studies did not evaluate the relative importance of liver-derived circulating IGF-I vs. that of IGF-I produced in peripheral tissues. In LI-IGF-I-/- mice of this study, the deficiency of endocrine, liver-derived IGF-I was induced at 1 or 12 months of age. Consequently, the mice likely developed normally but then underwent a maintained, selective inactivation of IGF-I in hepatocytes, but retained normal IGF-I expression in the peripheral tissues as shown in several previous studies , –, –. Therefore, the present study is the first to investigate life span in mice with normal IGF-I levels during development.
The extension of mean life span in LI-IGF-I mice with inactivation of liver-derived IGF-I was moderate (+10%), less than that observed in GH-deficient Ames and Snell dwarf mice , . However, in contrast to the long-lived dwarf mice, longitudinal growth is almost normal in LI-IGF-I mice and body weight decreases only moderately , . The results of some studies suggest that the availability of food  and GH status  during the first days or weeks of life can affect longevity in mice. Therefore, unaffected IGF-I levels during the first month of life before inactivation of liver-derived IGF-I could be of importance for the less marked extension of mean life span in LI-IGF-I-/- mice compared to Ames and Snell dwarf mice that have low GH and IGF-I levels also during early postnatal development , . Furthermore, the LI-IGF-I-/- mice display compensatory increased GH levels [geometric mean plasma GH concentration 3.1-fold higher than that in control mice , , ]. This increased GH secretion may exert a negative effect on life span in LI-IGF-I mice and the full importance of liver-derived circulating IGF-I for life span regulation is therefore difficult to evaluate. However, our study shows that a marked reduction of liver-derived circulating IGF-I, combined with a moderate increase in circulating GH levels, results in a small but significant increase in mean life span.
Mean life span increased significantly (16%) in female LI-IGF-I-/- mice, while male LI-IGF-I-/- mice showed only a non-significant trend toward increased longevity. Similarly, life span in Igf1r+/- mice increased significantly only in female mice . A human study showed decreased body height and reduced activity of the IGF-I receptor in female but not male offspring of long-lived centenarians . Furthermore, the consequences of low circulating GH/IGF-I values differ considerably between men and women with hypopituitary disease . Therefore, the importance of IGF-I for life span regulation appears to be partly gender-dependent across species.
Reduced body weight in LI-IGF-I-/- mice could be one mechanism for prolonged life span in these mice. Previous studies demonstrated gradually reduced body fat in LI-IGF-I-/- mice, at least partly mediated by the compensatory increase in GH secretion . In a previous study, body fat was unchanged after correction for the reduced body weight in mice with deficiency of liver-derived IGF-I . In the present study, late inactivation of liver-derived endocrine IGF-I (at 12 months of age) resulted in reduced body weight and decreased body fat also after correction for body weight. This late inactivation of IGF-I in hepatocytes may resemble the age-related decline in serum IGF-I observed in elderly humans more closely than early inactivation of liver-derived IGF-I in previous mouse models.
We detected no between-group differences in food intake, oxygen consumption at rest, or activity level, whereas oxygen consumption during submaximal exercise was increased in LI-IGF-I-/- mice. We previously observed an association between reduced energy expenditure during submaximal exercise and subsequent body fat accumulation in mice with global deficiency of interleukin-6 , . Furthermore, LI-IGF-I-/- mice bear some resemblance to fat-specific insulin receptor knockout (FIRKO) mice, which display leanness, increased energy expenditure, and enhanced longevity , .
Since fertility of both male and female mice was similar to the controls both in this study and a previous study of mice with deficiency of liver-derived IGF-I , changes in fertility did not cause increased mean life span in LI-IGF-I-/- mice. Furthermore, changes in cardiovascular risk factors likely do not explain increased longevity in the LI-IGF-I-/- mice, because these mice have increased blood pressure  and increased circulating levels of insulin and cholesterol . Insulin resistance and hyperinsulinemia are associated with increased ROS formation, a pro-inflammatory milieu, and a reduction of life span . Impaired phosphoinositide 3-kinase pathway, decreased NAD-dependent deacetylase sirtuin (Sirt) 1 activity, and telomere shortening may mediate the reduction of life span in conditions of hyperinsulinemia/insulin resistance . Furthermore, increased circulating levels of insulin may activate the IGF-I receptor . In the present study, the mRNA level of the IGF-I receptor was unchanged in LI-IGF-I-/- mice in all organs studied using microarray and in skeletal muscle as measured by RT-PCR. In another mouse model of deficiency of liver-derived IGF-I with approximately similar phenotype as that of LI-IGF-I-/- mice including insulin resistance , , IGF-I receptor mRNA levels were similar as those in control mice in multiple tissues . Tyrosine phosphorylation state of the IGF-I receptor in skeletal muscle was approximately similar in mice with deficiency of liver-derived IGF-I and control mice before and after IGF-I administration in one study , but otherwise little is known of the extent to which the IGF-I receptor is activated in mice with deficiency of liver-derived IGF-I. Therefore, the possibility cannot be excluded that increased insulin levels in LI-IGF-I-/- mice, by an activation of the IGF-I receptor or by other effects, could contribute to the less pronounced extension of life span in these mice compared to Ames and Snell dwarf mice or Igf1r+/− mice.
Microarray analyses performed to identify genes regulated by liver-derived IGF-I studied only female mice because mean life span increased significantly in female but not male LI-IGF-I-/- mice. Since we sought transcripts that were consistently regulated in several tissues, we analyzed tissue samples from liver, skeletal muscle, heart, fat (retroperitoneal fat) and bone (vertebrae). Three consistently regulated genes (Hspa1a, Hspa1b, and Ctgf) were identified and confirmed by RT-PCR analyses.
The Hspa1a and Hspa1b genes of LI-IGF-I-/- mice were downregulated in all tissues that expressed these genes. Hspa1a and Hspa1b encode members of the heat shock protein 70 (Hsp70) family. Hsp70 proteins are stressed-induced chaperones involved in cellular repair and maintenance mechanisms . In Drosophila melanogaster, experimentally induced overexpression of Hsp70 prolongs life span . However, expression of endogenous Hsp70 after heat stress exposure is reduced in long-lived Drosophila melanogaster resistant to heat shock . In humans, increased Hsp70 expression has been implicated in the development of atherosclerosis  and may also participate in the progression of some cancers . Therefore, drugs that modulate the heat shock response are being developed . In long-lived dwarf mice, the regulation of heat shock proteins is complex and partly organ-specific, but in accord with the present results, some in vitro and in vivo data suggest reduced expression of heat shock proteins in dwarf mice with low GH/IGF-I activity , . Therefore, inhibition of genes encoding heat shock proteins may be of importance for the increased life span of mice with low IGF-I activity, which is in some accordance with the hypothesis that longevity correlates with lower basal levels of heat shock protein gene expression and more robust heat shock response . An effect of the GH/IGF-I axis on stress systems also somewhat concurs with previous findings that nematodes and fruit flies , ,  as well as mouse strains with low IGF-I activity , , including mice with deficiency of liver-derived IGF-I , display increased resistance to oxidative stress.
The mRNA levels of Ctgf were also affected in the LI-IGF-I-/- mice. Abnormal amplification of Ctgf-dependent signals results in failure to terminate tissue repair, leading to pathological scarring in conditions such as fibrosis and cancer . It is well known that GH treatment increases serum IGF-I level as well as collagen formation . Long-lived Snell dwarf mice with low GH/IGF-I activity have delayed collagen aging in terms of age-dependent collagen cross-linking . Thus, inhibition of Ctgf expression by deficiency of liver-derived endocrine IGF-I might delay aging, at least in terms of collagen aging.
Mean life span was 22.5 months in the control mice, which is approximately similar to the controls in Igf1r+/− mice studied by Holzenberger et al. , but lower than that in wildtype C57Bl/6J mice reported by the Jackson Laboratory (http://www.jax.org/). The shorter life span in our control mice compared to wildtype C57Bl/6J mice could be due to the genetic construction that the control mice were carrying (exon 4 of the IGF-I gene flanked by loxP sites) or due to differences in the environment or handling of the mice. In the present study, necropsies were not performed. However, in this as well as in our previous studies of LI-IGF-I-/- mice of various ages, we have not observed any signs of a specific stress or disease in these mice , –, –.
In the previous study by Holzenberger et al., low IGF-I activity in Igf1r+/− mice resulted in increased mean life span whereas the effect on maximal life span was moderate . In LI-IGF-I-/- mice, maximal lifespan was unaffected in the total group of mice and in male mice and only non-significantly tended to be increased in female mice. The possibility cannot be fully excluded that the effect on maximal life span was small because deficiency of liver-derived IGF-I only had a marginal effect on biological aging in late life, and that increased mean life span in LI-IGF-I-/- mice mainly was due to increased resistance to stresses in their environment during their entire life span.
In conclusion, adult inactivation of liver-derived, endocrine IGF-I results in a modest but significant increase in mean life span, an effect that is more predominant in female than male LI-IGF-I-/- mice. A contributing mechanism for the increased mean life span might be reduced body weight due to reduced body fat, which might partly result from increased energy expenditure during exercise. A consistent regulation of three genes in several tissues might directly or indirectly be of importance for the increased longevity in LI-IGF-I-/- mice by modulating stress response and collagen aging.
Materials and Methods
Animals and serum IGF-I
The LI-IGF-I-/- mice were generated as described previously (C57BL/6 background) , –. Mice homozygous for LoxP  and heterozygous for Mx-Cre  received three ip injections of polyinosinic-polycytidylic acid (PiPc; 6.25 µg/g body weight; Sigma-Aldrich Corp., Stockholm, Sweden) to induce expression of the Cre protein, thereby inactivating the IGF-I gene in the liver . This treatment was given at one month of age to study life span, fertility, oxygen consumption at submaximal exercise, and gene expression, or at 12 months of age to measure food intake, oxygen consumption at rest, activity level, and body composition. PiPc-treated littermates, homozygous for LoxP but lacking Mx-Cre, were used as controls. Seven days after the PiPc injections, serum was obtained and assayed for IGF-I by a double-antibody IGF-binding protein-blocked RIA (Mediagnost, Tübingen, Germany). The animals had free access to fresh water and food pellets (B&K Universal AB, Sollentuna, Sweden). The ethical committee at the University of Gothenburg approved this study. Ethical approval number: 92-2004.
Body weight and life span were determined in 137 (67 female and 70 male) control mice and 84 (31 female and 53 male) LI-IGF-I-/- mice. Fertility was determined in 5- and 8-month-old female and male control and LI-IGF-I-/- mice (n = 12–14 in each group). Energy expenditure was assessed in 24-month-old female control (n = 8) and LI-IGF-I-/- (n = 5) mice and during submaximal exercise in 18-month-old female control (n = 7) and LI-IGF-I-/- (n = 7) mice. Microarray analyses of gene expression in liver, skeletal muscle, heart, fat, and bone (vertebrae) were performed in female control (n = 6) and LI-IGF-I-/- (n = 7) mice.
In additional experiments, liver-derived IGF-I was inactivated at 12 months of age. This late inactivation of IGF-I in hepatocytes resemble the age-related decline in serum IGF-I observed in elderly humans more closely than inactivation of liver-derived IGF-I in early adult life. Food intake, indirect calorimetry at rest, and spontaneous activity level were assessed in 13-month-old female control (n = 8) and LI-IGF-I-/- (n = 8) mice one month following inactivation of liver-derived IGF-I and before there was any between-group difference in body weight. Dual-energy X-ray absorptiometry (DEXA) determined body composition in male control (n = 8) and LI-IGF-I-/- (n = 6) mice at 18 months of age, 6 months following inactivation of liver-derived IGF-I at 12 months of age, and weights of fat pads were also determined.
Fertility, body composition and food consumption
Fertility was assessed by mating female or male LI-IGF-I mice with control mice of opposite gender and the proportion of pregnant female mice and the litter size were determined.
Body composition was assessed using dual-energy X-ray absorptiometry (DEXA; PIXImus, Lunar Corporation, Madison, Michigan, USA). Total body fat and total body lean mass were measured from the lower level of the head to the inferior level of the first tail vertebra (the maximal scan area of the DEXA). Food intake and feces output were measured every 24 hours while mice were kept individually in metabolic cages for 5 days with free access to chow and drinking water, and the 3 last days were used for analyses.
Activity measurement and indirect calorimetry
Mice were housed in separate chambers during these experiments. Spontaneous physical activity was measured using a photocell-based activity monitor (Opto-Max; Columbus Instruments, Columbus, OH). Interruption of four infrared photocells on the short side and eight photocells on the long side of the cage recorded the activity. Broken beams were recorded every 30 seconds for 2 hours, and the last hour was used for analysis.
The volume of O2 consumed (VO2) and CO2 produced (VCO2) were measured by an Oxymax system (Columbus Instruments) for 120 min at 30°C (thermoneutrality). A steady-state was reached after 90 min and the following 30 min between 90 and 120 min were used for analysis. VCO2 and VO2 were measured every sixth min as the mean of every second measurement. Respiratory exchange ratio (RER) was measured as the ratio of VCO2 to VO2.
Energy expenditure during submaximal exercise
Mice were exercised on a motorized treadmill (Columbus Instruments) with an adjustable belt speed (0–100 m/min) and inclination (−10° to 25°). The treadmill was connected to the Oxymax system (Columbus Instruments) for measurement of energy expenditure by indirect calorimetry. The mice were encouraged to run by gentle tapping on their back. Before the experiments, all mice were acclimatized to the treadmill during a 3-day period with 5 min of rest and 5 min of running at 10 m/min and 0° inclination each day. On the test day, the mice rested for 1–2 h in the treadmill at room temperature (23°C) and then ran at a fixed speed of 10 m/min with an inclination of 0° for 30 min, followed by a 20 min post-exercise rest period.
DNA microarray analysis and bioinformatics
RNA from liver, skeletal muscle, heart, fat (retroperitoneal fat) and bone (vertebrae) was extracted from 6 control and 7 LI-IGF-I-/- mice by Tri Reagent (Sigma, St. Louis, MO, USA) and purified using spin columns from Rneasy Total RNA Isolation Kit (Qiagen, Chatsworth, CA, USA). For microarray analysis, the RNA samples were pooled three or two, resulting in three pools per group while for the confirmatory RT-PCR analyses individual mice (n = 6–7) were analyzed. The pooled RNA was reverse transcribed into cDNA, labeled, and analyzed by DNA microarray (MG-U74Av2 Array; Affymetrix, Santa Clara, CA, USA). The microarray data is MIAME compliant and can be accessed at EMBL-EBI ArrayExpress repository, ArrayExpress accession: E-MEXP-3026.
Scanned output files were analyzed using Affymetrix Micro Array Suite version 4.0.1 software (Affymetrix). To allow comparison of gene expression, the gene chips were globally scaled to an average intensity of 500. Each of the three LI-IGF-I-/- chips was compared with the three control chips, generating a total of nine comparison files. Only the genes that were regarded as “changed” according to the Affymetrix algorithm in four to nine of the comparisons were selected for further analysis. We then calculated an average-fold change for the nine comparisons of the selected genes. For a gene to be regarded as consistently regulated in the LI-IGF-I-/- mice, the average-fold increase or decrease of the nine comparisons was set as at least 1.5 fold in at least 4 of the 5 analyzed organs.
Real-time PCR analysis
To confirm the microarray findings, we performed RT-PCR analyses on skeletal muscle (triceps) samples from individual mice (n = 6–7) (ABI Prism 7700 Sequence Detection System (PE Applied Biosystems, Stockholm, Sweden). We used FAM-labeled probes specific for heat shock protein 1A (Mm01159846_s1) and 1B (Mm03038954_s1), connective tissue growth factor (Mm01192931_g1), CCAAT/enhancer protein delta (Mm00514291_s1), and IGF-I receptor (Mm00802831_m1). The reporter fluorescent dye VIC, specific for 18S rRNA, was included as an internal standard. The cDNA was amplified at 1 cycle at 50 C for 2 min and 95 C for 10 min, followed by 40 cycles at 95 C for 15 sec and 60 C for 1 min. We calculated the mRNA amount of each gene using the standard curve method (multiplex reaction, User Bulletin no. 2, PE Applied Biosystems).
All descriptive statistical results are presented as the mean ± SEM. Between-group differences were calculated using unpaired t-tests. Differences between survival curves were determined using Cox's test. Maximum lifespan was calculated as the number of mice that were alive (and number dead) at the age at which 90% of the joint distribution (LI-IGF-I-/- plus control mice) had died , . A two-tailed p<0.05 was considered significant.
The authors are grateful to Maud Petersson and Anette Hansevi at the Department of Internal Medicine for excellent technical assistance.
Presented in part at the Fourth International Congress of the GRS and the IGF Society, Genoa, Italy, September 2008.
Conceived and designed the experiments: JS KS JF NA OI J-OJ CO. Performed the experiments: JS KS JF NA OI J-OJ CO. Analyzed the data: JS KS JF NA OI J-OJ CO. Contributed reagents/materials/analysis tools: JS KS JF NA OI J-OJ CO. Wrote the paper: JS KS JF NA OI J-OJ CO. All authors contributed to the design and performance of the experiments, analysis of data, and preparation of the manuscript.
- 1. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R (1993) A C. elegans mutant that lives twice as long as wild type. Nature 366: 461–464.C. KenyonJ. ChangE. GenschA. RudnerR. Tabtiang1993A C. elegans mutant that lives twice as long as wild type.Nature366461464
- 2. Kimura K, Tissenbaum H, Liu Y, Ruvkun G (1997) daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277: 942–946.K. KimuraH. TissenbaumY. LiuG. Ruvkun1997daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans.Science277942946
- 3. Clancy D, Gems D, Harshman L, Oldham S, Stocker H, et al. (2001) Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292: 104–106.D. ClancyD. GemsL. HarshmanS. OldhamH. Stocker2001Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein.Science292104106
- 4. Tatar M, Kopelman A, Epstein D, Tu M, Yin C, et al. (2001) A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292: 107–110.M. TatarA. KopelmanD. EpsteinM. TuC. Yin2001A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function.Science292107110
- 5. Brown-Borg H, Borg K, Meliska C, Bartke A (1996) Dwarf mice and the ageing process. Nature 384: 33.H. Brown-BorgK. BorgC. MeliskaA. Bartke1996Dwarf mice and the ageing process.Nature38433
- 6. Flurkey K, Papaconstantinou J, Miller R, Harrison D (2001) Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci U S A 98: 6736–6741.K. FlurkeyJ. PapaconstantinouR. MillerD. Harrison2001Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production.Proc Natl Acad Sci U S A9867366741
- 7. Coschigano K, Clemmons D, Bellush L, Kopchick J (2000) Assessments of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141: 2608–2613.K. CoschiganoD. ClemmonsL. BellushJ. Kopchick2000Assessments of growth parameters and life span of GHR/BP gene-disrupted mice.Endocrinology14126082613
- 8. Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, et al. (2003) IGF-I receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421: 182–187.M. HolzenbergerJ. DupontB. DucosP. LeneuveA. Geloen2003IGF-I receptor regulates lifespan and resistance to oxidative stress in mice.Nature421182187
- 9. Conover C, Bale L (2007) Loss of pregnancy-associated plasma protein A extends lifespan in mice. Aging Cell 6: 727–729.C. ConoverL. Bale2007Loss of pregnancy-associated plasma protein A extends lifespan in mice.Aging Cell6727729
- 10. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, et al. (1999) The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402: 309–313.E. MigliaccioM. GiorgioS. MeleG. PelicciP. Reboldi1999The p66shc adaptor protein controls oxidative stress response and life span in mammals.Nature402309313
- 11. Kurosu H, Yamamoto M, Clark J, Pastor J, Nandi A, et al. (2005) Suppression of aging in mice by the hormone Klotho. Science 309: 1829–1833.H. KurosuM. YamamotoJ. ClarkJ. PastorA. Nandi2005Suppression of aging in mice by the hormone Klotho.Science30918291833
- 12. Yuan R, Tsaih S, Petkova S, de Evsikova C, Xing S, et al. (2009) Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels. Aging Cell 8: 277–287.R. YuanS. TsaihS. PetkovaC. de EvsikovaS. Xing2009Aging in inbred strains of mice: study design and interim report on median lifespans and circulating IGF1 levels.Aging Cell8277287
- 13. Broughton S, Partridge L (2009) Insulin/IGF-like signalling, the central nervous system and aging. Biochem J 418: 1–12.S. BroughtonL. Partridge2009Insulin/IGF-like signalling, the central nervous system and aging.Biochem J418112
- 14. Piriz J, Muller A, Trejo J, Torres-Aleman I (2011) IGF-I and the aging mammalian brain. Exp Gerontol 46: 96–99.J. PirizA. MullerJ. TrejoI. Torres-Aleman2011IGF-I and the aging mammalian brain.Exp Gerontol469699
- 15. Kappeler L, Filho CM, Dupont J, Leneuve P, Cervera P, et al. (2008) Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism. PLoS Biol 28: e254.L. KappelerCM FilhoJ. DupontP. LeneuveP. Cervera2008Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism.PLoS Biol28e254
- 16. Kenyon C (2005) The plasticity of aging: insights from long-lived mutants. Cell 120: 449–460.C. Kenyon2005The plasticity of aging: insights from long-lived mutants.Cell120449460
- 17. Kaletsky R, Murphy C (2010) The role of insulin/IGF-like signaling in C. elegans longevity and aging. Dis Model Mech 3: 415–419.R. KaletskyC. Murphy2010The role of insulin/IGF-like signaling in C. elegans longevity and aging.Dis Model Mech3415419
- 18. Berryman D, Christiansen JS, Johannson G, Thorner M, Kopchick J (2008) Role of the GH/IGF-1 axis in lifespan and healthspan: Lessons from animal models. Growth Horm IGF Res 18: 455–471.D. BerrymanJS ChristiansenG. JohannsonM. ThornerJ. Kopchick2008Role of the GH/IGF-1 axis in lifespan and healthspan: Lessons from animal models.Growth Horm IGF Res18455471
- 19. Fontana L, Partridge L, Longo V (2010) Extending healthy life span - from yeast to humans. Science 328: 321–326.L. FontanaL. PartridgeV. Longo2010Extending healthy life span - from yeast to humans.Science328321326
- 20. Bartke A, Wright J, Mattison J, Ingram D, Miller R, et al. (2001) Extending the lifespan of long-lived mice. Nature 414: 412.A. BartkeJ. WrightJ. MattisonD. IngramR. Miller2001Extending the lifespan of long-lived mice.Nature414412
- 21. Raffaello A, Rizzuto R (2011) Mitochondrial longevity pathways. Biochim Biophys Acta 1813: 260-268. pp. 260–268.A. RaffaelloR. Rizzuto2011Mitochondrial longevity pathways.Biochim Biophys Acta 1813260-268260268
- 22. Tullet J, Hertweck M, An J, Baker J, Hwang J, et al. (2008) Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell 132: 1025–1038.J. TulletM. HertweckJ. AnJ. BakerJ. Hwang2008Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans.Cell13210251038
- 23. Avogaro A, de Kreutzenberg S, Fadini G (2010) Insulin signaling and life span. Pflugers Arch 459: 301–314.A. AvogaroS. de KreutzenbergG. Fadini2010Insulin signaling and life span.Pflugers Arch459301314
- 24. Sjögren K, Liu J, Blad K, Skrtic S, Vidal O, et al. (1999) Liver-derived insulin-like growth factor I (IGF-I) is the principle source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A 96: 7088–7092.K. SjögrenJ. LiuK. BladS. SkrticO. Vidal1999Liver-derived insulin-like growth factor I (IGF-I) is the principle source of IGF-I in blood but is not required for postnatal body growth in mice.Proc Natl Acad Sci U S A9670887092
- 25. Yakar S, Liu J, Stannard B, Butler A, Accili D, et al. (1999) Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A 96: 7324–7329.S. YakarJ. LiuB. StannardA. ButlerD. Accili1999Normal growth and development in the absence of hepatic insulin-like growth factor I.Proc Natl Acad Sci U S A9673247329
- 26. Ohlsson C, Mohan S, Sjögren K, Tivesten A, Isgaard J, et al. (2009) The role of liver-derived insulin-like growth factor-I. Endocr Rev 30: 494–535.C. OhlssonS. MohanK. SjögrenA. TivestenJ. Isgaard2009The role of liver-derived insulin-like growth factor-I.Endocr Rev30494535
- 27. Sjögren K, Wallenius K, Liu J, Bohlooly-Y M, Pacini G, et al. (2001) Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes 50: 1539–1545.K. SjögrenK. WalleniusJ. LiuM. Bohlooly-YG. Pacini2001Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism.Diabetes5015391545
- 28. Sjögren K, Sheng M, Moverare S, Liu J, Wallenius K, et al. (2002) Effects of liver-derived insulin-like growth factor I on bone metabolism in mice. J Bone Miner Res 17: 1977–1987.K. SjögrenM. ShengS. MoverareJ. LiuK. Wallenius2002Effects of liver-derived insulin-like growth factor I on bone metabolism in mice.J Bone Miner Res1719771987
- 29. Wallenius K, Sjögren K, Peng X, Park S, Wallenius V, et al. (2001) Liver-derived IGF-I regulates GH secretion at the pituitary level in mice. Endocrinology 142: 4762–4770.K. WalleniusK. SjögrenX. PengS. ParkV. Wallenius2001Liver-derived IGF-I regulates GH secretion at the pituitary level in mice.Endocrinology14247624770
- 30. Tivesten A, Bollano E, Andersson I, Fitzgerald S, Caidahl K, et al. (2002) Liver-derived insulin-like growth factor-I is involved in the regulation of blood pressure in mice. Endocrinology 143: 4235–4242.A. TivestenE. BollanoI. AnderssonS. FitzgeraldK. Caidahl2002Liver-derived insulin-like growth factor-I is involved in the regulation of blood pressure in mice.Endocrinology14342354242
- 31. Lindberg M, Svensson J, Venken K, Chavoshi T, Andersson N, et al. (2006) Liver-derived IGF-I is permissive for ovariectomy-induced trabecular bone loss. Bone 38: 85–92.M. LindbergJ. SvenssonK. VenkenT. ChavoshiN. Andersson2006Liver-derived IGF-I is permissive for ovariectomy-induced trabecular bone loss.Bone388592
- 32. Svensson J, Söderpalm B, Sjögren K, Engel J, Ohlsson C (2005) Liver-derived IGF-I regulates exploratory activity in old mice. Am J Physiol Endocrinol Metab 289: E466–E473.J. SvenssonB. SöderpalmK. SjögrenJ. EngelC. Ohlsson2005Liver-derived IGF-I regulates exploratory activity in old mice.Am J Physiol Endocrinol Metab289E466E473
- 33. Svensson J, Diez M, Engel J, Wass C, Tivesten Å, et al. (2006) Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice. J Endocrinol 189: 617–627.J. SvenssonM. DiezJ. EngelC. WassÅ. Tivesten2006Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice.J Endocrinol189617627
- 34. Svensson J, Tivesten Å, Sjögren K, Isaksson O, Bergström G, et al. (2007) Liver-derived IGF-I regulates kidney size, sodium reabsorption, and renal IGF-II expression. J Endocrinol 193: 359–366.J. SvenssonÅ. TivestenK. SjögrenO. IsakssonG. Bergström2007Liver-derived IGF-I regulates kidney size, sodium reabsorption, and renal IGF-II expression.J Endocrinol193359366
- 35. Svensson J, Kindblom J, Shao R, Movérare-Skrtic S, Lagerquist M, et al. (2008) Liver-derived IGF-I enhances the androgenic response in prostate. J Endocrinol 199: 489–497.J. SvenssonJ. KindblomR. ShaoS. Movérare-SkrticM. Lagerquist2008Liver-derived IGF-I enhances the androgenic response in prostate.J Endocrinol199489497
- 36. Sun L, Sadighi Akha A, Miller R, Harper J (2009) Life-span extension in mice by preweaning food restriction and by methionine restriction in middle age. J Gerontol A Biol Sci Med Sci 64: 711–722.L. SunA. Sadighi AkhaR. MillerJ. Harper2009Life-span extension in mice by preweaning food restriction and by methionine restriction in middle age.J Gerontol A Biol Sci Med Sci64711722
- 37. Panici J, Harper J, Miller R, Bartke A, Spong A, et al. (2010) Early life growth hormone treatment shortens longevity and decreases cellular stress resistance in long-lived mutant mice. FASEB J 24: 5073–5079.J. PaniciJ. HarperR. MillerA. BartkeA. Spong2010Early life growth hormone treatment shortens longevity and decreases cellular stress resistance in long-lived mutant mice.FASEB J2450735079
- 38. Suh Y, Atzmon G, Cho M-O, Hwang D, Liu B, et al. (2008) Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci U S A 105: 3438–3442.Y. SuhG. AtzmonM-O ChoD. HwangB. Liu2008Functionally significant insulin-like growth factor I receptor mutations in centenarians.Proc Natl Acad Sci U S A10534383442
- 39. Drake W, Howell S, Monson J, Shalet S (2001) Optimizing gh therapy in adults and children. Endocr Rev 22: 425–450.W. DrakeS. HowellJ. MonsonS. Shalet2001Optimizing gh therapy in adults and children.Endocr Rev22425450
- 40. Yakar S, Canalis E, Sun H, Mejia W, Kawashima Y, et al. (2009) Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions. J Bone Miner Res 24: 1481–1492.S. YakarE. CanalisH. SunW. MejiaY. Kawashima2009Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions.J Bone Miner Res2414811492
- 41. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, et al. (2002) Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8: 75–79.V. WalleniusK. WalleniusB. AhrenM. RudlingH. Carlsten2002Interleukin-6-deficient mice develop mature-onset obesity.Nat Med87579
- 42. Fäldt J, Wernstedt I, Fitzgerald S, Wallenius K, Bergström G, et al. (2004) Reduced exercise endurance in interleukin-6-deficient mice. Endocrinology 145: 2680–2686.J. FäldtI. WernstedtS. FitzgeraldK. WalleniusG. Bergström2004Reduced exercise endurance in interleukin-6-deficient mice.Endocrinology14526802686
- 43. Blüher M, Kahn B, Kahn C (2003) Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299: 572–574.M. BlüherB. KahnC. Kahn2003Extended longevity in mice lacking the insulin receptor in adipose tissue.Science299572574
- 44. Katic M, Kennedy A, Leykin I, Norris A, McGettrick A, et al. (2007) Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out mice. Aging Cell 6: 827–839.M. KaticA. KennedyI. LeykinA. NorrisA. McGettrick2007Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out mice.Aging Cell6827839
- 45. Le Roith D, Bondy C, Yakar S, Liu J-L, Butler A (2001) The Somatomedin Hypothesis: 2001. Endocr Rev 22: 53–74.D. Le RoithC. BondyS. YakarJ-L LiuA. Butler2001The Somatomedin Hypothesis: 2001.Endocr Rev225374
- 46. Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, et al. (2001) Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 50: 1110–1118.S. YakarJL LiuAM FernandezY. WuAV Schally2001Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity.Diabetes5011101118
- 47. Daugaard M, Rohde M, Jäättelä M (2007) The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions. FEBS Lett 581: 3702–3710.M. DaugaardM. RohdeM. Jäättelä2007The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions.FEBS Lett58137023710
- 48. Tatar M, Khazaeli A, Curtsinger J (1997) Chaperoning extended life. Nature 390: 30.M. TatarA. KhazaeliJ. Curtsinger1997Chaperoning extended life.Nature39030
- 49. Norry F, Loeschcke V (2003) Heat-induced expression of a molecular chaperone decreases by selecting for long-lived individuals. Exp Gerontol 38: 673–681.F. NorryV. Loeschcke2003Heat-induced expression of a molecular chaperone decreases by selecting for long-lived individuals.Exp Gerontol38673681
- 50. Svensson P, Asea A, Englund M, Bausero M, Jernås M, et al. (2006) Major role of HSP70 as a paracrine inducer of cytokine production in human oxidized LDL treated macrophages. Atherosclerosis 185: 32–38.P. SvenssonA. AseaM. EnglundM. BauseroM. Jernås2006Major role of HSP70 as a paracrine inducer of cytokine production in human oxidized LDL treated macrophages.Atherosclerosis1853238
- 51. Powers M, Workman P (2007) Inhibitors of heat shock response: Biology and pharmacology. FEBS Lett 581: 3758–3769.M. PowersP. Workman2007Inhibitors of heat shock response: Biology and pharmacology.FEBS Lett58137583769
- 52. Maynard S, Miller R (2006) Fibroblasts from long-lived Snell dwarf mice are resistant to oxygen-induced in vitro growth arrest. Aging Cell 5: 89–96.S. MaynardR. Miller2006Fibroblasts from long-lived Snell dwarf mice are resistant to oxygen-induced in vitro growth arrest.Aging Cell58996
- 53. Swindell W, Masternak M, Kopchick J, Conover C, Bartke A, et al. (2009) Endocrine regulation of heat shock protein mRNA levels in long-lived dwarf mice. Mech Ageing Dev 130: 393–400.W. SwindellM. MasternakJ. KopchickC. ConoverA. Bartke2009Endocrine regulation of heat shock protein mRNA levels in long-lived dwarf mice.Mech Ageing Dev130393400
- 54. Tower J (2009) Hsps and aging. Trends Endocrinol Metab 20: 216–222.J. Tower2009Hsps and aging.Trends Endocrinol Metab20216222
- 55. Li Q, Yang X, Sreejayan N, Ren J (2007) Insulin-like growth factor I deficiency prolongs survival and antagonizes paraquat-induced cardiomyocyte dysfunction: role of oxidative stress. Rejuvenation Res 10: 501–511.Q. LiX. YangN. SreejayanJ. Ren2007Insulin-like growth factor I deficiency prolongs survival and antagonizes paraquat-induced cardiomyocyte dysfunction: role of oxidative stress.Rejuvenation Res10501511
- 56. Shi-Wen X, Leask A, Abraham D (2008) Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev 19: 133–144.X. Shi-WenA. LeaskD. Abraham2008Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis.Cytokine Growth Factor Rev19133144
- 57. Ohlsson C, Bengtsson B-Å, Isaksson O, Andreassen T, Slootweg M (1998) Growth hormone and bone. Endocr Rev 19: 55–79.C. OhlssonB-Å BengtssonO. IsakssonT. AndreassenM. Slootweg1998Growth hormone and bone.Endocr Rev195579
- 58. Liu J, Grinberg A, Westphal H, Sauer B, Accili D, et al. (1998) Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice. Mol Endocrinol 12: 1452–1462.J. LiuA. GrinbergH. WestphalB. SauerD. Accili1998Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: manipulation using the Cre/loxP system in transgenic mice.Mol Endocrinol1214521462
- 59. Kuhn R, Schwenk F, Aguet M, Rajewsky K (1995) Inducible gene targeting in mice. Science 269: 1427–1429.R. KuhnF. SchwenkM. AguetK. Rajewsky1995Inducible gene targeting in mice.Science26914271429
- 60. Wang C, Li Q, Redden D, Weindruch R, Allison B (2004) Statistical methods for testing effects on “maximum lifespan”. Mech Ageing Dev 125: 629–632.C. WangQ. LiD. ReddenR. WeindruchB. Allison2004Statistical methods for testing effects on “maximum lifespan”.Mech Ageing Dev125629632
- 61. Harrison D, Strong R, Sharp Z, Nelson J, Astle C, et al. (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460: 392–395.D. HarrisonR. StrongZ. SharpJ. NelsonC. Astle2009Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.Nature460392395